Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest.
Aug 2026· Vaccine· Vol 91, pp.
129058
· 0 citations· 48 references
Medicine
TL;DR
Strengthening public confidence, primary care capacity, school-based delivery, and digital monitoring may help close immunization gaps and accelerate progress toward cervical cancer elimination.
Abstract
Background
Human papillomavirus (HPV) vaccination represents a cornerstone of cervical cancer prevention and is essential to achieving the WHO elimination targets in Europe. The study aimed to assess HPV vaccination coverage trends among adolescent females across Europe, identify key predictors of uptake, and evaluate the association between the introduction of HPV vaccination into National Immunization Programmes (NIPs) and public interest, as reflected by online search activity.
Methods
This country-level longitudinal study analysed available 2010-2023 full-dose HPV vaccination coverage data among 15-year-old females across 43 European countries, by years since introduction within the NIPs. Socioeconomic, institutional, health-system, and delivery indicators were integrated with Google Trends Relative Search Volume for the "HPV vaccine" topic. Multivariable GEE models were used to identify predictors of vaccination coverage, while Pearson correlations assessed the association between Relative Search Volume and coverage.
Results
Coverage among adolescent females increased markedly after NIP introduction, with population-weighted coverage reaching about 40% by year 2 and stabilising at 55-60% by year 5. Coverage exceeded 60% in most countries by year 15. Multivariable analyses identified lower public disagreement with vaccine safety and higher physician density as significant determinants, with interactions between time since NIP introduction and HDI. School-based programmes were associated with a faster increase. Among 32 countries with Google Trends data, 53% showed significant Relative Search Volume changes after NIP introduction, and Relative Search Volume strongly correlated with coverage (r = 0.89).
Conclusions
HPV vaccination coverage among adolescent females in Europe remains uneven and below the WHO 90% target. Strengthening public confidence, primary care capacity, school-based delivery, and digital monitoring may help close immunization gaps and accelerate progress toward cervical cancer elimination.
Introduction Human papillomavirus (HPV) is a leading cause of both cervical and non-cervical cancers, including anal, oropharyngeal, vaginal and vulvar cancers. While most HPV vaccination impact assessments have focused on preventing cervical cancer among women, the broader benefits of vaccination against other HPV-att...
A. Tuli, M. Jit, K. Abbas et al.· BMJ Global Health· 0 citations
BACKGROUND
Human papillomavirus (HPV) vaccinations were introduced in the Swedish National Immunization Program (NIP) for girls in 2012. This study aims to examine socioeconomic factors among schoolgirls and their parents associated with low HPV vaccine uptake (first dose) according to the NIP schedule (aged 11-13 year...
Emma Appelqvist, E. Löf, S. Kühlmann-Berenzon et al.· Vaccine· 0 citations
Summary Background HPV vaccination coverage among 18-year-old women in Germany was 61% in 2024, despite the recommendation for girls since 2007. We assessed the association between HPV vaccination and risk of precancerous lesions and invasive cervical cancer in Bavaria, Germany's largest state. Methods We conducted a r...
Gifty Baffour Awuah, Sandra Fett, Gunther Schauberger et al.· The Lancet Regional Health -...· 0 citations
Introduction In Europe, cervical cancer (CC) is the third most common gynaecologic cancer, and the second among women under the age of 45. CC screening uptake is highly variable across the region, and especially low among vulnerable groups. Current evidence suggests that HPV (Human Papilloma Virus) vaccination benefits...
Isabel Mosquera, A. Tisler, A. T. Ramírez et al.· Cancer Control: Journal of t...· 0 citations
Background: Cervical cancer remains a major public health problem, causing approximately 660,000 new cases and 348,000 deaths annually, with more than 90% occurring in low- and middle-income countries. The WHO African Region accounts for approximately 20% of global cases and 30% of deaths. In November 2020, the World H...
A. Bwaka, Sambo Guemgo, Marcellin Mengouo Nimpa et al.· Vaccines· 0 citations
Cervical cancer remains one of the most preventable yet persistently fatal cancers affecting women worldwide, largely because persistent infection with High-Risk Human Papillomavirus (HPV) genotypes is now recognized as a necessary precursor in nearly all cases. Vaccinating adolescent girls against HPV before sexual de...
Karpagavalli Nageswaran, Shraddhadip Koitiya· Journal of Midwifery, Women...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.